DALLAS -- The U.S. Food and Drug Administration is calling for stricter safety rules for a product used by tens of thousands of women. The move comes after a News 8 report last week on transvaginal ...

CHICAGO — The ban on further sales of transvaginal mesh for pelvic organ prolapse (POP) imposed by the US Food and Drug Administration (FDA) last month has some people cheering, some saying that an ...

December 26, 2008 — Trocar-guided transvaginal mesh surgery for pelvic organ prolapse results in good clinical outcomes at 1 year, according to the results of a prospective, multicenter cohort study ...

Boston Scientific and Coloplast—the two remaining U.S. manufacturers of transvaginal surgical mesh—have been ordered by the FDA to halt the sale and distribution of those products across the country, ...

ORLANDO, FLA. — An Orlando doctor and Michigan consultant are accused by federal authorities in a nationwide scheme to persuade women to take on debt and travel long distances to remove controversial ...

(Reuters) - A Michigan medical funder was ordered to pay about $1.3 million on Monday for his role in a scheme to convince women to have unnecessary surgery to remove their transvaginal mesh implants ...

NEW YORK (Reuters) -Boston Scientific Corp agreed to pay $188.7 million to settle claims by most U.S. states that it deceptively marketed its surgical mesh devices to consumers. The settlement with 47 ...

Please provide your email address to receive an email when new articles are posted on . Transvaginal mesh was noninferior to native tissue repair in women with pelvic organ prolapse at 36 months, ...

A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh, a device that is the subject of more than 25,000 lawsuits against ...

Doctor admits to plot to remove mesh from women after settlements in mesh litigation Surgical funder also pleads guilty (Reuters) - A Florida doctor admitted Friday to his role in a plot to convince ...

On Wednesday, the Australian Senate recommended that transvaginal mesh, a pelvic implant used to address prolapse, only be used as a last resort. These guidelines are similar to those already in place ...

The U.S. Food and Drug Administration today issued two final orders to manufacturers and the public to strengthen the data requirements for surgical mesh to repair pelvic organ prolapse (POP) ...